Category: biotech

.Merck &amp Co. has actually picked up options on two Evaxion Biotech vaccination candidates, paying $3.2 thousand as well as hanging more than $1 billion

.Merck &amp Co. is taking down $30 thousand in advance to acquire Yale spinout Modifi Biosciences, a bargain that consists of a preclinical possession made

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.’s HER3-directed antibody-drug conjugate (ADC) has actually hit its primary endpoint, increasing programs to

.Merck &amp Co.’s long-running effort to land a punch on tiny cell lung cancer cells (SCLC) has actually acquired a little success. The drugmaker’s Daiichi

.MBX has elaborated plannings to enjoy over $136 million coming from its IPO as the biotech tries to carry a possible challenger to Ascendis Pharma’s

.Gilead Sciences and also Merck &amp Co. have guided their once-weekly HIV combination treatment past another milestone, linking the cocktail to sustained reductions of the

.Following a poor showing for Lykos Therapies’ MDMA candidate for post-traumatic stress disorder at a latest FDA advisory board appointment, the various other shoe possesses

.MBX Biosciences has included in the latest spurt of IPO filings. The biotech, which submitted its paperwork weeks after raising $63.5 thousand confidentially, is seeking

.Psychopharmacology has drawn 3 short articles concerning midstage scientific test records evaluating Lykos Rehabs’ investigational MDMA prospect for dealing with post-traumatic stress disorder (POST-TRAUMATIC STRESS

.Lykos Therapies might have shed three-quarters of its staff in the wake of the FDA’s turndown of its MDMA candidate for trauma, but the biotech’s